Related StoriesStudy discovers high prevalence of dehydration in the elderly living in UK treatment homesDisclosing genetic risk for CHD outcomes in lower low-density lipoprotein cholesterolScreening for asymptomatic atrial fibrillation could decrease threat of stroke, premature deathLipitor isn’t for everyone. It isn’t suitable for people that have liver complications or for females who are nursing, pregnant, or could become pregnant. Around 20 million Americans have problems with chronic kidney disease where in fact the kidneys cannot successfully filter the poisons from the blood, that may result in kidney failure.GEMS is usually a novel technology that allows the discovery of medications that may increase or reduce the expression of a particular proteins by targeting regulatory mechanisms. It really is an alternative method of medication discovery and among its advantages may be the reality that GEMS delivers little molecules which can be used orally. Under the conditions of the contract, AstraZeneca can make an undisclosed up-entrance money payment for the initiation of the initial focus on in the collaboration plus dedicated study funding to PTC. Preliminary efforts will be centered on oncology with a chance to go after up to eight targets across different therapeutic areas.